Options for the Control of Influenza V, 1st Edition
Proceedings of the International Conference on Options for the Control of Influenza V held in Okinawa, Japan, between 7 and 11, October, 2003, ICS 1263
Author :
Yoshihiro Kawaoka
Date of Publication: 07/2004
As researchers unravelled the mysteries of these new viruses, drug companies navigated new antiviral therapies designed to treat and prevent influenza through clinical trials.The continual development of new antivirals and control measures underscore ...view more
As researchers unravelled the mysteries of these new viruses, drug companies navigated new antiviral therapies designed to treat and prevent influenza through clinical trials.The continual development of new antivirals and control measures underscores not only the significance of influenza,but highlights options for the control of influenza.
As researchers unravelled the mysteries of these new viruses, drug companies navigated new antiviral therapies designed to treat and prevent influenza through clinical trials.The continual development of new antivirals and control measures underscores not only the significance of influenza,but highlights options for the control of influenza.
Author Information
Edited by Yoshihiro Kawaoka, Professor, Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokoyo, Tokoyo, Japan
https://www.mea.elsevierhealth.com/options-for-the-control-of-influenza-v-9780444516398.html95982Options for the Control of Influenza Vhttps://www.mea.elsevierhealth.com/media/catalog/product/9/7/9780444516398_1.jpg464.55489USDInStock/Medicine and Surgery/Infectious Disease/Books9971525503913733745145120As researchers unravelled the mysteries of these new viruses, drug companies navigated new antiviral therapies designed to treat and prevent influenza through clinical trials.The continual development of new antivirals and control measures underscores not only the significance of influenza,but highlights options for the control of influenza. As researchers unravelled the mysteries of these new viruses, drug companies navigated new antiviral therapies designed to treat and prevent influenza through clinical trials.The continual development of new antivirals and control measures underscores not only the significance of influenza,but highlights options for the control of influenza.USD00add-to-cart97804445163982011 and earlierProfessionalEdited by Yoshihiro Kawaoka20041BookOtherElsevier87816 Jul 2004PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSEdited by <STRONG>Yoshihiro Kawaoka</STRONG>, Professor, Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokoyo, Tokoyo, JapanBooksInternational CongressNoNoNoNoPlease SelectPlease SelectPlease Select
